Please login to the form below

Not currently logged in
Email:
Password:

Key role for French cluster in regenerative medicine project

Medicen Paris Region will be responsible for long-term impact of the BONE project

regenerative medicineFrench life science cluster the Medicen Paris Region has been recruited to play a key role in a newly-launched European regenerative medicine project.

The four-year, €3.3m BONE project will see impacts developed using electrospinning - a procedure that uses electric charges to pull fibres from liquid.

These impacts, produced by Maastricht University in the Netherlands, have been tipped to become an alternative to repeat surgeries, prolonged medication use and donor tissue.

Medicen, a cluster of 300 life science organisations, will be responsible for activities relating to the dissemination and long-term impact of the project, as well as overall monitoring and matchmaking.

Béatrice Falise-Mirat, CEO of Medicen Paris Region, said: “Regenerative medicine is one of our five strategic activities; it is important to position each one at the European level.

“It’s a wonderful example of inter-cluster collaboration internationally and the added value that clusters can provide for European ecosystems.”

The initiative will unite Maastricht, Leuven and Lille universities along with the Fraunhofer Institute for Laser Technology ILT in Germany and technology firms based in the UK, Denmark and Ireland.

“We are thrilled that we are able to position the cluster and, more specifically the Ile-de-France region, in such an international context,” Falise-Mirat added.

The project - funded by the Interreg North-West Europe Program - has a total budget of €3.3m ($3.8m), and it is expected that the cluster will benefit from 15 new jobs, two new products and €162,000 ($185,000) in funding spread over the course of the project.

Article by
Gemma Jones

28th July 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

R&D protocol amendments
Rethinking trials: the pros and cons of protocol amendments
Protocol amendments occur often and can be beneficial, but the steps involved can be complex...
Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...

Infographics